华南预防医学 ›› 2026, Vol. 52 ›› Issue (1): 7-11.doi: 10.12183/j.scjpm.2026.0007

• 论著 • 上一篇    下一篇

1996—2022年四川省凉山州昭觉县儿童HIV感染者生存状况及影响因素分析

赵宇腾1, 地门牟巫2, 卢绍荣2, 黎庆梅1, 韩志刚1   

  1. 1.广州市疾病预防控制中心,广东 广州 510440;
    2.凉山州昭觉县疾病预防控制中心
  • 收稿日期:2025-03-05 出版日期:2026-01-20 发布日期:2026-02-06
  • 作者简介:赵宇腾(1978—),男,硕士研究生,主任医师,研究方向为艾滋病/丙肝防治
  • 基金资助:
    中国性病艾滋病防治协会凉山州“三线一网底”能力建设开放式小额资助项目(LS2022OR01); 广州市科技计划基础与应用基础研究项目(202102080260,2025A03J3697)

Survival status and associated factors among children living with HIV in Zhaojue County, Liangshan Prefecture, Sichuan Province, 1996-2022

Zhao Yuteng1, Di Men Mouwu2, Lu Shaorong2, Li Qingmei1, Han Zhigang1   

  1. 1. Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong 510240, China;
    2. Zhaojue Center for Disease Control and Prevention
  • Received:2025-03-05 Online:2026-01-20 Published:2026-02-06

摘要: 目的 分析昭觉县儿童HIV感染者生存状况,探索影响患者生存时间的相关因素。方法 采用回顾性队列研究,收集1996—2022年现住址在昭觉县的儿童HIV感染者的随访信息,观察终点为2022年12月31日,用寿命表法计算累积生存率,以Log-Rank检验比较不同组间的生存时间差异,用Cox比例风险回归模型进行生存分析。结果 925例儿童HIV感染者平均观察时间66.0个月(95% CI:63.3~68.7),儿童HIV感染者随访6个月、1年、5年、10年及15年的累计生存率分别为95%、92%、87%、80%及73%。多因素Cox比例风险模型分析结果显示,人群分类为病例报告时间为1996—2008年(HR=0.331,95% CI:0.125~0.878)、2009—2017年(HR=1.742,95% CI:1.074~2.825)、抗病毒治疗情况为未治或脱失(HR=51.254,95% CI:32.221~81.531)以及HIV感染临床分期为III期(HR=9.527,95% CI:3.430~26.462)对儿童HIV患者生存时间的影响有统计学意义(均P<0.05)。结论 应重点提高报告时间为2009—2017年、尚未接受HIV抗病毒治疗且进入临床III期儿童HIV感染者抗病毒治疗覆盖率,尽快改善患者免疫功能,从而延长患者生存时间。

关键词: HIV, 儿童, 生存状况, 影响因素

Abstract: Objective To analyze the survival status of children living with HIV in Zhaojue County and to investigate the factors associated with their survival time. Methods A retrospective cohort study was conducted, compiling follow-up data for pediatric HIV patients residing in Zhaojue County between 1996 and 2022. The observation endpoint was December 31, 2022. The life table method was utilized to calculate cumulative survival rates. Differences in survival times across various subgroups were compared using the log-rank test, and a Cox proportional hazards regression model was employed to perform the survival analysis. Results The study cohort comprised 925 children living with HIV, with a mean observation time of 66.0 months (95% CI: 63.3-68.7). The cumulative survival rates at 6 months, 1 year, 5 years, 10 years, and 15 years were 95%, 92%, 87%, 80%, and 73%, respectively. Multivariate Cox proportional hazards regression analysis indicated that the period of case diagnosis (1996-2008: HR=0.331, 95% CI: 0.125-0.878; 2009-2017: HR=1.742, 95% CI: 1.074-2.825), treatment status (untreated or lost to follow-up: HR=51.254, 95% CI: 32.221-81.531), and WHO Clinical Stage III of HIV infection (HR=9.527, 95% CI: 3.430-26.462) were statistically significant predictors of survival time. Conclusion It is imperative to prioritize the expansion of antiretroviral therapy (ART) coverage for children living with HIV, especially those diagnosed between 2009 and 2017, those who are treatment-naïve, and those who have advanced to WHO Clinical Stage III. Expediting the restoration of patients' immune function is critical to prolonging their survival.

Key words: HIV, Pediatrics, Survival analysis, Associated factors

中图分类号: 

  • R179